Systematic review: Superparamagnetic Iron Oxide nanoparticles as contrast agents in diagnosis of multiple sclerosis

Authors

  • Fereshteh Fathi Department of Chemical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Science, Sari, Iran
  • Maryam Ghafari Cherati Department of Biological and Genetic, Faculty of Medicine, Mazandaran University of Medical Science, Sari, Iran
Abstract:

Several MRI contrast agents (CAs) are used in medical diagnosis that gadolinium (Gd3+) is the most widely used as contrast agents. Unfortunately, its toxicity is due to its inefficiency. In this review, we discuss about the ability of SPIONs in MRI and application in Multiple Sclerosis diagnosis. Superparamagnetic iron oxide nanoparticles (SPIONs) such as magnetite nanoparticles are used as good CAs in recent years because of biocompatibility, low level of toxicity, magnetic properties, simple synthesis and coating to use in medical diagnosis. Uncoated magnetite nanonoparticles are insoluble in water. Hydrophilic coatings result water solubility of nanoparticles and prolonged circulation half-lives of SPION and reduce recognition by RES. SPIONs have an important role in diagnosis of multiple sclerosis (MS) by MRI. SPIONs are MRI contrast agents better than gadolinium because, SPIONs taken up by macrophages but not Gd-nanoparticles.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

systematic review: superparamagnetic iron oxide nanoparticles as contrast agents in diagnosis of multiple sclerosis

several mri contrast agents (cas) are used in medical diagnosis that gadolinium (gd3+) is the most widely used as contrast agents. unfortunately, its toxicity is due to its inefficiency. in this review, we discuss about the ability of spions in mri and application in multiple sclerosis diagnosis. superparamagnetic iron oxide nanoparticles (spions) such as magnetite nanoparticles are used as goo...

full text

Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents

Iron oxide nanoparticles (IONPs) of low polydispersity were obtained through a simple polyol synthesis in high pressure and high temperature conditions. The control of the size and morphology of the nanoparticles was studied by varying the solvent used, the amount of iron precursor and the reaction time. Compared with conventional synthesis methods such as thermal decomposition or co-precipitat...

full text

Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking

Stem cells hold great promise for the treatment of multiple human diseases and disorders. Tracking and monitoring of stem cells in vivo after transplantation can supply important information for determining the efficacy of stem cell therapy. Magnetic resonance imaging (MRI) combined with contrast agents is believed to be the most effective and safest non-invasive technique for stem cell trackin...

full text

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

Medical imaging is routine in the diagnosis and staging of a wide range of medical conditions. In particular, magnetic resonance imaging (MRI) is critical for visualizing soft tissue and organs, with over 60 million MRI procedures performed each year worldwide. About one-third of these procedures are contrast-enhanced MRI, and gadolinium-based contrast agents (GBCAs) are the mainstream MRI cont...

full text

Dendronized iron oxide nanoparticles as contrast agents for MRI.

Covalent attachment, through a phosphonate anchor, of hydrophilic pegylated dendrons on iron oxide nanoparticles results in versatile, robust, and highly relaxing MRI contrast agents.

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue 4

pages  270- 277

publication date 2016-12-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023